iBio expands exclusive product collaboration with Novici Biotech
iBio and Novici Biotech have agreed to broaden their commercial collaboration, currently focused on antibodies and certain vaccine products, to include iBio's proprietary IBIO-CFB03 product for idiopathic pulmonary fibrosis, systemic sclerosis and other fibrotic diseases. October 22, 2014